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Abstract
The disparity in breast cancer mortality rates among white and black US women is widening,
with higher mortality rates among black women. We apply functional time series models on
age-speciﬁc breast cancer mortality rates for each group of women, and forecast their mortality
curves using exponential smoothing state-space models with damping.
The data were obtained from the Surveillance, Epidemiology and End Results (SEER) program of
the US (SEER, 2007). Mortality data were obtained from the National Centre for Health Statistics
(NCHS) available on the SEER*Stat database. We use annual unadjusted breast cancer mortality
rates from 1969 to 2004 in 5-year age groups (45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79,
80–84). Age-speciﬁc mortality curves were obtained using nonparametric smoothing methods.
The curves are then decomposed using functional principal components and we ﬁt functional
time series models with four basis functions for each population separately. The curves from
each population are forecast and prediction intervals are calculated.
Twenty-year forecasts indicate an over-all decline in future breast cancer mortality rates for both
groups of women. This decline is steeper among white women aged 55–73 and black women
aged 60–84. For black women under 55 years of age, the forecast rates are relatively stable
indicating no signiﬁcant change in future breast cancer mortality rates among young black
women in the next 20 years.
Keywords: Breast cancer mortality, racial and ethnic disparities, screening, trends, forecasting,
functional data analysis
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1 Introduction
Breast Cancer is the most common cancer among women in the United States excluding skin
cancers (American Cancer Society, 2007). It accounts for about 33% of all cancers diagnosed
in women (Smigal, Jemal, Ward, Cokkinides, Smith, Howe, and Thun, 2006). After cancer of
the lung, it is the second leading cause of cancer deaths (Jemal, Thomas, Murray, and Thun,
2002) with approximately 40480 women expected to die in 2008 (www.cancer.gov). Hence, it
is necessary and important to get accurate projections of age-speciﬁc breast cancer mortality
rates. These projections are of major public health interest. Their interpretations, however, may
be complex because they reﬂect the combined eﬀects of screening usage, trends in risk factors
and eﬀectiveness of treatments (Cheverley and White, 1997).
In the United States there are striking diﬀerences in breast cancer mortality in black and white
women and in other ethnicities such as Hispanics, but there is very little historical data on these
populations (see www.seer.cancer.gov). These diﬀerences are causing a long term divergence
in mortality trends between African American and white women. Many studies are showing
that the disparity in breast cancer death rates between whites and blacks continues to grow with
mortality rates higher among black women compared to white women (see, e.g., Joslyn, 2002;
Marbella and Layde, 2001; Tarone, Chu, and Gaudette, 1997).
In addition, there are major diﬀerences in breast cancer mortality in black and white women in
the US by age. In a study of age- and race-speciﬁc breast cancer mortality, Cheverley and White
(1997) reported an apparent decline in breast cancer mortality rates since 1992 among white
women across all ages. However, there was no signiﬁcant decline among white women aged
80 years and over or among black women of all ages. Smigal, Jemal, Ward, Cokkinides, Smith,
Howe, and Thun (2006) found a decreasing trend in breast cancer death rates of white women
at an average annual rate of 2.4% since 1990 and by 1.1% per year among black women since
1991.
However, few studies have predicted age-related changes in black/white breast cancer mortality.
Jatoi, Anderson, Rao, and Devesa (2005) used age-period-cohort (APC) models based on Poisson
regression and observed the changes occurring in mortality trends among white and black
women in the United States according to age, calendar period (year of death) and birth cohort
(year of birth). They observed that, for both races, the overall mortality rates increased with age,
but black women have higher rates at ages younger than 57.
Tyczynski, Hill, and Berkel (2006) observed breast cancer mortality rates by race and age in
Ohio and reported an overall decline in mortality since 1990. They used joinpoint regression
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and an APC model to evaluate temporal changes in mortality. Hanayama (2007) proposed an
extended version of the APC model for analysing (age, period) tabulated data on mortality and
ﬁtted the proposed model to breast cancer mortality data for women in the United States.
However, a limitation in these studies is that neither of them projected future breast cancer
mortality rates for white and black women taking account of age-related changes. These changes
need to be allowed for rather than assuming constant change in the age-mortality associations
for future years.
In this paper, we use functional data analysis (Ramsay and Silverman, 2005) to model age-
speciﬁc breast cancer mortality tends among white and black women in the United States.
We also use these models to predict future breast cancer mortality rates by age separately for
white and black women. These predictions are important for public health. To the best of our




The data were obtained from the Surveillance, Epidemiology and End Results (SEER) program
of the United States (SEER, 2007). Mortality data were obtained from the National Centre for
Health Statistics (NCHS) available on the SEER*Stat database. Annual age-speciﬁc breast cancer
mortality data are designated by ICD 8 & 9 (1979–1998) code 174 and ICD 10 (1999+) code
C50 and are available for the two racial groups, whites and blacks, and all races combined since
1969 in nineteen 5-year age-groups. However in this study, we analysed the data for eight age
groups: 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84.
2.2 Statistical Methods
To see the association between age and breast cancer mortality rates, we plot mortality-age
curves. These curves are plotted by treating the annual mortality rate as a function of the
mid-point of the age groups. Log mortality rates for all age groups were obtained separately for
white and black women.
From the original log mortality data, the ﬁrst step is to obtain smooth functions which we observe
with error (Hyndman and Ullah, 2007) (see the appendix for details). These are obtained using
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nonparametric smoothing methods. We treat the smooth curves as our functional observations.
Hence, we have two functional time series for white and black women.
To analyse these curves, we use functional time series models introduced by Hyndman and Ullah
(2007). They decomposed the smoothed curves via a basis function expansion using functional
principal components (Ramsay and Silverman, 2005). This approach gives a small number
of basis functions (functions of age) and gives time series coeﬃcients which are uncorrelated
with each other. We follow the same methodology as Erbas, Hyndman, and Gertig (2007) and
use functional regression models separately for white and black women. An adequate ﬁt for
both white and black women is obtained using a functional regression model with four basis
functions.
The time series coeﬃcients are forecast using univariate time series models. Here we use
exponential smoothing state-space models based on Hyndman, Koehler, Ord, and Snyder (2008),
which provide a statistical framework for automatic forecasting. These forecasts are then
multiplied with the estimated basis functions resulting in forecasts of the entire mortality age
curve.
This technique also provides computation of prediction intervals for the forecasts using the esti-
mated variance of error terms. Finally, we construct prediction intervals around our predictions
assuming the forecast errors are normally distributed.
We estimated twenty-year predictions of breast cancer mortality rates for white and black
women in the United States. All statistical analyses were performed in R version 2:10:1.
3 Results
Figure 1 displays age-speciﬁc mortality rates for breast cancer among white and black US
women during the study period (1969–2004). These graphs show that breast cancer mortality
rates among white women under 55 years declined slowly from 1969 and then quite sharply
after 1990. A similar decline started in 1988 for age-group 55–59.
The patterns for older white women (aged 60–79 years) are slightly diﬀerent. The rates ﬁrst
increased from 1970 to 1990 and then started to decline very sharply after that period. However,
for women aged 80–84 years, the rates increased from 1970, stabilized between 1988–1994 and
then declined after 1994.



















































































































Figure 1: Breast cancer mortality rates by age-groups among white and black US women (1969–
2004).






















































































































Figure 2: Log mortality rates for white and black US women (1969–2004). In the upper panel
original log rates are plotted whereas in the lower panel, log rates after smoothing are
plotted. Penalized regression splines are used to smooth the data. The curves are ordered
in time using rainbow colors. The oldest data (from 1969) is shown in red, with the most
recent data (from 2004) shown in purple.
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The patterns for breast cancer mortality rates among black women are more variable, especially
for women aged 65 years and above. Among African Americans, the rates slightly increased for
women aged 45–54 years and then started to decline from 1994. However, for age-group 55–59,
the decline started from 1990.
For black women of middle age (60–69) years, breast cancer mortality rates ﬁrst increased very
sharply after 1970 and then declined from 1990. There is a clear and sharp increasing trend for
black women aged 70 years and above until 1992. The rates started to decline from 1996 for age
group 70–74 years and since 1992 for women aged 75–79 years. However, the mortality rates
for black women aged 80–84 years have high variability compared to the other age groups, and
have declined since 2000.
The ﬁrst step in using functional time series models is to obtain smoothed log mortality rates.
We use penalized regression spline (Wood, 1994) for smoothing. The observed log mortality
rates and smoothed rates are given in Figure 2 using rainbow plots (Hyndman and Shang, 2010).
The ﬁrst row of Figure 2 shows exactly the same data as in Figure 1 but as functional data
instead of age-speciﬁc time series.
By looking at these graphs, we can see that before 1990, the mortality rates among black women
under 55 years of age were higher than those for the white women of same age. However for
older black women (65 and above) the rates were much smaller than the rates for white women.
For whites, the ﬁrst four basis functions in the functional model explain 86.6%, 10.2%, 2.9%
and 0.2% of the total variability in mortality rates, while in blacks they explain 77.6%, 14.3%,
5.4% and 1.2% of the total variability. Hence only four basis functions are suﬃcient to explain
about 99% of the total variability in breast cancer mortality rates of white and black women.
Figure 3 depicts the plots of the ﬁrst basis functions and corresponding coeﬃcients for the
models for each race. It is interesting to note that the ﬁrst basis function for white women
decreases with age while the corresponding function for black women increases with age. That
is, the major changes in breast cancer rates amongst white women occur at the younger ages,
while the major changes amongst black women occur at the older ages. The plot of the ﬁrst time
series coeﬃcient for white women shows that the mortality rates were almost unchanging from
1969 to 1988, and have since decreased. In contrast, the ﬁrst coeﬃcient for black women shows
that breast cancer mortality rates increased from 1969 to about 1992, were relatively stable
between 1992-1996, and have started to decline since 1997. We do not attempt to interpret the
other basis functions as they involve second-and higher-order eﬀects.
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Figure 3: First basis functions and ﬁrst coeﬃcients for whites and blacks with red color is used for





































Figure 4: 20-year mortality forecasts for the ﬁrst coeﬃcients of each model.
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We obtain 20-year predictions of the future mortality rates using exponential smoothing state-
space models of Hyndman, Koehler, Ord, and Snyder (2008) with damping. Figure 4 displays the
predictions of the ﬁrst coeﬃcient of future mortality rates. The forecasts are plotted separately
for white and black women along with 80% prediction intervals. From these graphs, it is clear
that the future mortality trends are decreasing for both white and black women.
By multiplying the forecasts of the coeﬃcients with the basis functions and summing the results,
we obtain forecasts of the entire mortality curves. Figures 5 and 6 represent 20-year forecasts
for the entire curves. These plots exhibit that the future mortality rates will decline for all ages,
but that the decline will be greatest for the oldest black women, and smallest for the youngest
black women. The changes for white women are more similar across the age range.
In Figures 7 and 8, we convert the functional forecasts back into age-group forecasts for
comparison with the historical rates.
To check the forecast uncertainty, we also plot the mortality forecasts for forecast horizons of
one and twenty years, along with 80% prediction intervals for the two races. These are given in
ﬁgures 9 and 10 respectively. The estimated predictions have narrow bands for white women
and young black women under 60 years. However, they are much wider for older black women
due to more variability among the historical mortality rates. Some forecasts at selected ages are
shown in Table 1, along with 80% prediction intervals.
White Women Black Women
Age Forecast 2005 Forecast2024 Forecast 2005 Forecast 2024
Mean 80% PI Mean 80% PI Mean 80% PI Mean 80% PI
45 16.6 [15.5, 17.8] 8.7 [ 4.9, 15.6] 35.3 [ 30.4, 41.0] 33.7 [21.1, 53.6]
50 27.6 [ 26.7, 28.4] 16.9 [12.8, 22.3] 50.8 [ 47.9, 53.9] 47.2 [37.6, 59.1]
55 41.6 [ 40.5, 42.7] 28.2 [22.3, 35.9] 67.0 [ 62.9, 71.3] 60.5 [49.7, 73.5]
60 55.2 [ 53.5, 56.9] 39.9 [30.7, 51.8] 77.6 [ 72.8, 82.8] 67.4 [52.9, 85.8]
65 67.8 [ 66.0, 69.6] 52.1 [41.4, 65.5] 84.5 [ 79.1, 90.3] 70.4 [51.6, 95.8]
70 82.3 [ 80.1, 84.6] 67.2 [53.6, 84.2] 95.3 [ 89.7, 101.3] 77.5 [57.2, 105.0]
75 100.8 [ 98.2, 103.5] 87.1 [70.8, 107.1] 113.4 [106.7, 120.6] 91.2 [67.8, 122.7]
80 123.4 [120.6, 126.4] 112.9 [94.5, 134.9] 136.8 [126.0, 148.5] 107.7 [70.8, 163.9]
Table 1: Forecasts and 80% prediction intervals of mortality rates for selected ages in 2005 and 2024
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Figure 5: 20-year forecasts (2005–2024) for breast cancer mortality rates for white women. The years
are plotted in “rainbow” order with the later years in violet.






































Figure 6: 20-year forecasts (2005–2024) for breast cancer mortality rates for black women. The years
are plotted in “rainbow” order with the later years in violet.





























































































Figure 8: 20-year forecasts (2005–2024) for breast cancer mortality rates for black women by age-
group.
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Figure 9: One-year forecast (for 2005) for breast cancer mortality rate along with 80% prediction
intervals.










































Figure 10: 20-year forecast (for 2024) for breast cancer mortality rate along with 80% prediction
intervals.
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4 Discussion
In this paper, we have presented the functional forecasting method for age-related predictions
of black and white breast cancer mortality in the United States. We have shown that white
women have smooth and consistent patterns in breast cancer mortality rates for all age-groups
whereas the mortality curves for black women are much more variable. During the most recent
years, mortality rates for black women have been higher than those from white women for all
age groups under 80 years of age. Our analysis suggests black American women do not bene.t
equally from the overall decline in breast cancer mortality in the United States.
Our models show that the most important source of variability in mortality rates for white
women is in the younger ages, while black women show greatest variability amongst older
women. All breast cancer mortality rates are expected to decline. The greatest rate of decline in
white women is expected for ages between 55–74 years (see Figures 5 and 6). For black women,
the plot of the forecasts shows that there the rates will decline very slowly for women aged
under 60 years. However, they will decline signiﬁcantly for the older black women (age 70 and
above).
Our results are consistent with results found by other studies such as Smigal, Jemal, Ward,
Cokkinides, Smith, Howe, and Thun (2006), Tyczynski, Hill, and Berkel (2006) and Chu, Tarone,
and Brawley (1999) in the sense that they showed that the over-all breast cancer mortality rates
in US have declined in the last two decades. This decrease is due to the advances in detection and
diagnosis and improvements in the treatments of breast cancer (Canto, Anderson, and Brawley,
2001; Cheverley and White, 1997; Chu, Tarone, and Brawley, 1999). However, the mortality
rates for white and black women are signiﬁcantly diﬀerent. This disparity started in the 1990s
as a result of a sharp improvement in mortality among white women with no improvement
for black women (Hirschman, Whitman, and Ansell, 2007). Studies have also shown that there
are racial disparities in almost every step of the breast cancer process, including detection,
treatment and survival (Chelbowski, Chen, Anderson, Rohan, Aragasi, Lane, Dolan, Paskett,
McTiernan, Hubbel, Adams-Campbell, and Prentice, 2005; Li, Malone, and Daling, 2003).
Tarone, Chu, and Gaudette (1997) found an increase in mortality calendar period slope in the
1980s compared with the 1970s for all women, and then a decreasing mortality trend from
1991 only for white women. During the 1980s, the larger increase in the mortality calendar
period slope for black women could reﬂect the higher stage at diagnosis for them (Tarone, Chu,
and Gaudette, 1997). The signiﬁcant decrease during the 1990s in calendar period mortality
slope for US white women supports the conclusion that this decrease in mortality is due to
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medical interventions (Chu, Tarone, Kessler, Ries, Hankey, and Miller, 1996). During this
period, similar decreases have been observed in UK (Quinn and Allen, 1995) and Canada (Chu,
Tarone, Kessler, Ries, Hankey, and Miller, 1996). This may be due to increased use of adjuvant
therapy, particularly tamoxifen therapy, and the use of early detection (Briele, Walker, Wild,
Wood, Greager, Schneebaum, Silva-Lopez, Han, Gunter, Tapas, and Gupta, 1990; Quinn and
Allen, 1995). A large percentage of young white women (age 20 to 59) years were obtaining
regular clinical breast cancer examinations (Makuc, Fried, and Klienman, 1989) and that may
have contributed to long term decline of breast cancer mortality in this group (Foster, Worden,
Costanza, and Solomon, 1992).
There are many reasons for the slower decline in mortality rates for black women including
racial diﬀerences in mammography use. The reasons for this disparity may be diﬀerential access
to mammography among black and white women, diﬀerential quality in mammography and
diﬀerential access to the breast cancer treatments (Hirschman, Whitman, and Ansell, 2007). The
percentages of women who have ever received a clinical breast examination or mammogram
are lower in older black women than in older white women (Caplan, Wells, and Haynes, 1992).
Black women are usually less likely than white women to be aware of the use of screening tests
and the women with low education level and low cancer knowledge are less likely to be clinical
breast exam or mammogram compliant (Harris, Miller, and Davis, 2003).
Other possible explanations for the racial trends in breast cancer mortality include socioeco-
nomic status, stage of disease and tumor biology (Marbella and Layde, 2001). Studies showed
that black women usually have lower socioeconomic status (Farley and Flannery, 1989) and
are more likely to be diagnosed with advanced stage of breast cancer than white women (Be-
ral, Hermon, Reevas, and Peto, 1995; Eley, Hill, and Chen, 1994; Elledge, Clark, Chamness,
and Osbome, 1994). In breast cancer tumor characteristics, such as hormone receptor status,
signiﬁcant racial diﬀerences have been found so that black women exhibit more aggressive
aspects of disease (Elmore, Meceri, Carter, and Larson, 1998; Gapstur, Dupuis, Gann, Collila,
and Winchester, 1996). However, one study showed that despite black women tending to present
with higher-stage of breast cancer disease, their tumors do not seem to be more aggressive and
equal treatments may yield equal outcomes (Chu, Tarone, and Brawley, 1999). Black women
have been shown to be less likely than whites to have any insurance, and are less likely to
be covered by a private insurance carrier (Blendon, Aiken, Freeman, and Corey, 1989). This
suggests that disparity may be due to diﬀerent access to health care and more cultural and
economic programs are needed to remove barriers from early detection for black women. More
breast cancer education programmes are needed in order to attract the attention of black women
and to educate them about screening programs (Sadler, Ko, Cohn, White, Weldon, and Wu,
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2007). In another study, Newman and Alfonso (1997) found that breast cancer mortality may be
high among young black women and biologically, their cancers are more aggressive among the
subset of young women. They recommended that young black women should be targeted for
aggressive breast cancer screening.
Women aged 40–64 years can beneﬁt from mammography in reducing the risk of death from
breast cancer (Norman, Localio, Weber, Coates, Zhou, Bernstein, Malone, Marchbanks, Weiss,
Lee, and Nadel, 2007). Mammography screening is more eﬀective in older women (aged 50–64
years) than in younger women (aged 40–49). Screening eﬃcacy is usually greater in post-
menopausal women; as the breast density aﬀects mammographic sensitivity (Carney, Miglioretti,
Yankaskas, Kerlikowske, Rosenberg, Rutter, Geller, Abraham, Taplin, Dignan, Cutter, and
Ballard-Barbash, 2003) and density decreases after menopause (Stone, Gunasekara, Martin,
Yaﬀe, Minkin, and Boyd, 2003).
Among black women, higher mortality rates may be due to lower serum 25-hydroxyvitamin D
[25(OH)D] caused by lower vitamin D production rates from solar ultraviolet-B irradiance due
to their darker skin (Grant, 2006). Black Americans generally have lower 25(OH)D levels than
white Americans (Harkness and Cromer, 2005; Looker, Hughes, Calvo, Gunter, and Sahyoun,
2002). Several cancers (including breast cancer) behave more aggressively in blacks than whites
due to this lower rate of 25(OH)D (Studzinski and Moore, 1995); this aggressiveness aﬀects
survival rates from cancer (Giovannucci, 2005).
However, some results are slightly diﬀerent. Jatoi, Anderson, Rao, and Devesa (2005) observed
that for both white and black women, the overall mortality rates increased with age, but black
women have higher rates at ages younger than 57. They observed a decreasing trend in mortality
rates for both black and white women until the late 1970s. Thereafter, a sharp decline was
evident in the calendar period slope for whites, whereas blacks experienced an increase in
this slope which stabilized around 1995. After that period, mortality rates decreased for black
women with a diﬀerent rate of change than those for whites and nonwhites. However, their
analysis is based on age-adjusted (2000 US standard) mortality rates per 100,000 woman-years .
The age-related trends in mortality were adjusted for period (and cohort) factors and calendar
period trends were adjusted for age (and cohort) factors.
In contrast, we performed the analysis for all age groups of white and black women and found
that during the most recent years, the mortality rates were higher for blacks in all age groups
than the mortality rates for whites except for the oldest age group (see Figure 1). We found that
the breast cancer mortality rates for the young white women (age 45–60 years) decreased very
slowly from 1970 until 1990 whereas they increased for older white women (age 65 years and
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above) until 1988. After that they started to decline for all ages and more sharply for the older
white women.
However for black women, the rates were slightly increasing for younger women (age 45–59
years) during the study period until 1995 and then started to decline. For older black women
(age 65 and above), there is a prominent increasing trend until 1992 and then the rates declined
but little bit slowly as compared to white. However for women age 80 and above, the rates are
too much ﬂuctuated and declined in most recent years.
Marbella and Layde (2001) found that black women had no signiﬁcant change in breast cancer
mortality during the periods 1989–1992 and 1993–1996, whereas white women experienced
a signiﬁcant decrease during this time period. They analyzed the data from 1981 to 1996. In
our analysis, we found a decline in breast cancer mortality rates for whites from 1989 and for
blacks from 1996.
4.1 Strengths
Here, we are using an alternative approach to the most widely used APC models for forecasting
mortality rates. We use a recently developed method for demographic forecasting by Hyndman
and Ullah (2007) which makes use of all available historical data rather than only the most
recent observations. This new approach has a number of advantages. At ﬁrst, it allows us to
model mortality rates as continuous functions of age to capture the patterns of variation between
years. The data are ﬁrst smoothed before estimating the basis functions and their coeﬃcients to
reduce observational error. Our approach forecasts the entire function for future time periods
with prediction intervals. Our method also has the potential to incorporate important covariates
such as mammographic screening and treatment eﬀects such as hormone replacement therapy.
In contrast, the APC models include strong parametric assumptions about the distribution of
error and assume exact linear dependency between the three variables (age, period and cohort).
Also, there are problems in identiﬁcation of parameters as these models are sensitive to changes
in recent patterns of birth cohorts. The extended APC model proposed by Hanayama (2007)
provides a better ﬁt to the data than traditional models, but they analysed the data for all US
females. Also, they used 10-year age-groups and periods so detailed age-based discussion is not
possible. In their analysis, the residuals showed systematic departures from proposed models
and this suggests the model is inadequate.
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4.2 Limitations
However, there are some limitations in our new method. Our models only consider calendar
period (year of death) eﬀects and do not incorporate cohort (year of birth) eﬀects. Calendar
period mortality trends reﬂect the impact of new medical interventions whereas birth cohort
mortality trends can reﬂect changes in risk factors. There may be some other factors, such
as screening and treatment options associated with hormone replacement therapy, that could
change the entire shape of mortality curve. We are not considering these options here, but in
future we aim to extend our models so cohort eﬀects can also be incorporated.
In summary, this study utilises recent approaches in the statistical analysis of age-speciﬁc
mortality rates to model future age-speciﬁc breast cancer induced mortality rates amongst
two groups of American women, namely whites and blacks. These projections provide a clear
indication that although overall mortality of breast cancer is set to decline, the current disparity
between the two groups will increase, with some variation between age groups, thus highlighting
those groups of American women most at risk of death due to breast cancer.
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Appendix
Suppose yk;t(xi) denotes the log mortality rate at age xi in year t for the kth group (k = 1;2).
Here, white and black women are considered to be group 1 and 2 respectively. We assume that
yk;t(xi) = fk;t(xi)+k;t(x)"k;t;i; (1)
where ffk;t(x)g is a smooth function of x, k;t(x) allows the amount of noise to vary with x, and
f"k;t;ig are considered to be independent and identically distributed random variables with zero
mean and unit variance.
The ﬁrst step is to estimate these smooth functions from the discrete noisy data. This is possible
using nonparametric smoothing methods such as penalized regression splines (Ruppert, Wand,
and Carroll, 2003) or loess curves (Cleveland and Devlin, 1988).






where k(x) is the mean log mortality across years for the kth group and fj;k(x)g is a set of
orthogonal basis functions for each k. The values fk;j;1;:::;k;j;ng form a univariate time series
for each k = 1;2 and j = 1;:::;J. The basis functions fj;k(x)g are computed using functional
principal components (Ramsay and Silverman, 2005) applied to the smooth curves fk;t(x).
The h-step ahead forecast of ˆ yn+h;k(x) can be obtained as
ˆ yn+h;k(x) = ˆ k(x)+
J X
j=1
ˆ k;j;n+h ˆ j;k(x); (3)
where ˆ k(x) and ˆ j;k(x) are the estimates of the mean function and basis functions respectively
and ˆ k;j;n+h denotes the h-step ahead forecast of k;j;n+h computed using a state space exponential
smoothing model (Hyndman, Koehler, Ord, and Snyder, 2008).
Hyndman and Ullah (2007) showed that the forecast variance can be obtained by adding the
variances of all individual terms as







Yasmeen, Hyndman and Erbas: April 2010 22Forecasting age-related changes in breast cancer mortality among white and black US women
where ˆ 2
(x) is the variance obtained using the smoothing method, uk;j;n;h = Var(k;j;n+h j
k;j;1;:::;k;j;n) is the forecast variance from the time series model, (x) is obtained using the sum
of squared residuals, and 2
n+h(x) can be obtained using a Poisson approximation (see Hyndman
and Ullah, 2007, for details). After substituting the values of all these terms in (4), one may
obtain prediction intervals for the entire mortality curve, assuming a normal distribution for
the forecast errors.
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